Last reviewed · How we verify

NCT07007013

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study

Active, enrolled NA Last updated 5 December 2025
What this trial tests

NA trial testing Humor therapy in Medically Unexplained Symptoms in 28 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 September 2025
Primary endpoint
19 November 2025
1 May 2026

Quick facts

Lead sponsorConsorci Sanitari de l'Alt Penedès i Garraf
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment28
Start date1 September 2025
Primary completion19 November 2025
Estimated completion1 May 2026
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf — full company profile →

Who can join

18 and older, any sex, with Medically Unexplained Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to study the effectiveness of the intervention for medically unexplained symptoms(MUS) in terms of changes in emotional well-being before and after the intervention (humor therapy)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Medically Unexplained Symptoms

Currently open trials in the same condition.

Other Consorci Sanitari de l'Alt Penedès i Garraf trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07007013.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing